STAT

With the Nobel Prizes around the corner, it’s crystal ball time

The scientists who pioneered immunotherapy and other cancer advances are among the favorites for this year's Nobel Prizes, which will be announced the first week of October.

Really, we at STAT love autophagy, the cell’s garbage disposal. Also those adorable little molecular machines. Discoveries about the former won the Nobel Prize in medicine last year for Yoshinori Ohsumi, while three inventors of the latter won the chemistry prize. But if Bob Dylan can win the literature Nobel, can science Nobels go to researchers whose work has a contemporary flair and direct relevance to what matters to the public?

We’re looking at you, Jim Allison of MD Anderson Cancer Center, Gordon Freeman of Dana-Farber Cancer Institute, and Dr. Arlene Sharpe of Harvard Medical School — or, we think the Nobel Committee choosing the medicine

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
STAT2 min read
STAT+: Brain Biopsies On ‘Vulnerable’ Patients At Mount Sinai Set Off Alarm Bells At FDA, Documents Show
A STAT Investigation: Brain biopsies on "vulnerable" patients at Mount Sinai set off alarm bells at FDA, documents show.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Boy Dying In Pfizer Trial; AstraZeneca Yanking Covid Shot, And More
A young boy died in a clinical trial for an experimental Pfizer gene therapy for Duchenne muscular dystrophy, about a year after receiving the therapy.

Related